“TC BioPharm (NASDAQ:TCBP): Cancer Treatment Patent Issued!
UPDATE 10/7/24 Since our last update on TC Biopharm (NASDAQ: TCBP), a clinical-stage biopharmaceutical company making bold strides in the realm of cell therapy, the stock has been experiencing remarkable trading activity, pointing to a highly compelling opportunity for investors keeping a close eye on small-cap stocks. Over the past five trading days, TCBP’s stock […]